Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118876302 | 11887630 | 2 | F | 19970408 | 20160827 | 20160105 | 20160829 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-B032731 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 0.00000 | 20160829 | OT | US | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118876302 | 11887630 | 1 | PS | VIDEX | DIDANOSINE | 1 | Transplacental | UNK | 20156 | TABLET | |||||||||
| 118876302 | 11887630 | 2 | SS | ZERIT | STAVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118876302 | 11887630 | 3 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118876302 | 11887630 | 4 | SS | CRIXIVAN | INDINAVIR SULFATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118876302 | 11887630 | 5 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118876302 | 11887630 | 6 | SS | RETROVIR | ZIDOVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 118876302 | 11887630 | 7 | C | FUNGIZONE | AMPHOTERICIN B | 1 | Transplacental | UNK | U | 0 | SOLUTION FOR INFUSION | ||||||||
| 118876302 | 11887630 | 8 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118876302 | 11887630 | 9 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118876302 | 11887630 | 1 | Product used for unknown indication |
| 118876302 | 11887630 | 2 | Product used for unknown indication |
| 118876302 | 11887630 | 3 | Product used for unknown indication |
| 118876302 | 11887630 | 4 | Product used for unknown indication |
| 118876302 | 11887630 | 5 | Product used for unknown indication |
| 118876302 | 11887630 | 6 | Prophylaxis |
| 118876302 | 11887630 | 7 | Product used for unknown indication |
| 118876302 | 11887630 | 8 | Product used for unknown indication |
| 118876302 | 11887630 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118876302 | 11887630 | CA |
| 118876302 | 11887630 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118876302 | 11887630 | Bone development abnormal | |
| 118876302 | 11887630 | Congenital aplastic anaemia | |
| 118876302 | 11887630 | Dilatation ventricular | |
| 118876302 | 11887630 | Duodenal atresia | |
| 118876302 | 11887630 | Facial paralysis | |
| 118876302 | 11887630 | Foetal exposure during pregnancy | |
| 118876302 | 11887630 | Foetal growth restriction | |
| 118876302 | 11887630 | Multiple congenital abnormalities | |
| 118876302 | 11887630 | Pupillary disorder | |
| 118876302 | 11887630 | Renal aplasia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |